SMi presents the 9thannual conference on:ADMETEnhancing drug quality by ADMET optimisation in discoveryThe Marriott Regents Park Hotel, London UK30THJUNE – 1STJULY 2014ADMET 2014 will enable delegates to gain valuable insights into enhancing drug quality by ADMET optimisation in discovery. It will focus on themes including Predictive ADME, Screening Approaches, Predictive Toxicology, Drug to Drug interactions and emerging issues such as regulatory changes.Previous events in the ADMET series have received positive feedback from the industry including,"Excellent" – Pharmidex, "Nice mix of attendees" – Grunenthal, "Good conference at general level to update your current knowledge" - Orion Corporation and "Great conference…well organised" - SanofiKey Speakers Include:Natalie Gobeau, Metabolism and Pharmacokinetics, NovartisDietmar-Weitz, Lab Head/ADME In Vitro Systems, Sanofi-AventisSarah Baldwin, In Vitro DMPK Manager, GSKChris Powell, VP Safety Assessment, GSKGeorg Schmitt, Head of Toxicology, Roche PharmaceuticalsRichard Thompson, Principal Scientist, AstraZenecaFranck Atienzar, Associate Director, In Vitro and In Silico Toxicology, UCBAdina Tocoian, Senior Clinical Pharmacologist, UCBDavid Fairman, Senior Clinical Pharmacokinetist, MedImmune Reasons to Join:Best Practices – Share ideas with industry leaders to identify cutting-edge developments including peptides in drug discovery, the use of label free technologies in drug development, 3D cell culture to predict hepatotoxity, computational models and evolving transporter strategies.Strategy – Aid your drug development and hear case study driven presentations from leading academia and pharmaceutical KOLS including Novo Nordisk, Medlmmune, Roche, GSK, Astra Zeneca, Imperial College London, Genetech, Novartis and Sanofi-Aventis.Industry - Learn about hot topics with unique insights into accurate human dose prediction, immunogenicity, H-bonding, cardiac safety, PBPK, pharmacokinetics, risk assesment plus much moreRegulation – Receive regulatory direction on drug transporters and obtain a comparative review of the EMA vs. FDA guidelines for immunogenicity of biologicsThe Future – Look ahead into the rapidly changing field of computational biology and learn how to apply this approach to ADMET and to your own project. Peer to peer networking - Ample opportunity for discussion, including 2 morning coffee breaks, 2 networking lunches and 2 afternoon tea sessions. Make new contacts, meet old friends and immerse yourself in a universe of new insightsContact the Team on +44 (0)20 7827 6000